{"filing":{"accession_number":"0001619856-26-000047","cik":"0001619856","ticker":"CRBU","company_name":"Caribou Biosciences, Inc.","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"crbu-20260617.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985626000047/crbu-20260617.htm"},"events":[{"id":11796,"run_id":10375,"accession_number":"0001619856-26-000047","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This is a clear disclosure of shareholder vote results from Caribou Biosciences' June 17, 2026 annual meeting of stockholders, filed under Item 5.07. The filing presents voting tallies for four proposals: election of three Class II directors (all passed), ratification of Deloitte \u0026 Touche LLP as auditor (passed), approval of officer exculpation amendment (failed), and approval of meeting adjournment (passed). The election of directors and auditor ratification are material governance events affecting investor assessment of board composition and audit oversight.","company_name":"Caribou Biosciences, Inc.","ticker":"CRBU","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8474,"accession_number":"0001619856-26-000047","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder vote results from Caribou Biosciences' June 17, 2026 annual meeting of stockholders, filed under Item 5.07. The filing presents voting tallies for four proposals: election of three Class II directors (all passed), ratification of Deloitte \u0026 Touche LLP as auditor (passed), approval of officer exculpation amendment (failed), and approval of meeting adjournment (passed). The election of directors and auditor ratification are material governance events affecting investor assessment of board composition and audit oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:04:44.724648+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8474,"accession_number":"0001619856-26-000047","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder vote results from Caribou Biosciences' June 17, 2026 annual meeting of stockholders, filed under Item 5.07. The filing presents voting tallies for four proposals: election of three Class II directors (all passed), ratification of Deloitte \u0026 Touche LLP as auditor (passed), approval of officer exculpation amendment (failed), and approval of meeting adjournment (passed). The election of directors and auditor ratification are material governance events affecting investor assessment of board composition and audit oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:04:44.724648+00:00","company_name":"Caribou Biosciences, Inc.","ticker":"CRBU","filing_date":"2026-06-18"}]}